EUROFINS SCIENTIFIC ORD SHS
ERFSF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$16.57B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $16.57 Billion |
|---|---|
| Enterprise Value | $21.61 Billion |
| Annual dividend | $0.84 |
| Dividend yield | 0.82% |
| Earnings per Share | $2.64 |
| Beta | 0.86 |
| Outstanding Shares | 175,500,000 |
Return
| Return on Equity | 24.03% |
|---|---|
| Return on Assets | 7.83% |
| Return on Invested Capital | 18.83% |
Valuation & Multiples
| P/E Ratio | 29.24 |
|---|---|
| PEG | 130.15 |
| Price to Sales | 1.35 |
| Price to Book Ratio | 4.87 |
| Enterprise Value to Revenue | 1.69 |
| Enterprise Value to EBIT | 13.32 |
| Enterprise Value to Net Income | 24 |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | 1.56 |
Revenue Sources
No data
Last Earnings Call
Report Date
July 29, 2026
EPS Estimate
$2.18
Consensus analyst estimateRevenue Estimate
$4.23 B
Consensus analyst estimateNext Earnings Call
Expected Date
January 28, 2027
EPS Estimate
$1.80
Consensus analyst estimateRevenue Estimate
$4.24 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Eurofins Scientific SE
65,000 employees
CEO: Gilles G. Martin
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental ...